1. Home
  2. BYSI

as 10-29-2025 9:37am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Founded: 2010 Country:
United States
United States
Employees: N/A City: FLORHAM PARK
Market Cap: 73.4M IPO Year: 2017
Target Price: N/A AVG Volume (30 days): 52.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.03 EPS Growth: N/A
52 Week Low/High: $0.98 - $3.44 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Stock Insider Trading Activity of BeyondSpring Inc. (BYSI)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 17 '25 Sell $1.76 45,513 $80,102.88 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 16 '25 Sell $1.72 85,798 $147,572.56 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 15 '25 Sell $1.65 17,960 $29,634.00 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 14 '25 Sell $1.65 28,495 $47,016.75 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 13 '25 Sell $1.70 107,361 $182,513.70 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 10 '25 Sell $1.77 2,390 $4,230.30 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 9 '25 Sell $1.81 3,979 $7,201.99 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 8 '25 Sell $1.77 7,507 $13,287.39 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 7 '25 Sell $1.79 2,100 $3,759.00 1,518,893
Decheng Capital China Life Sciences USD Fund III, L.P. BYSI 10% Owner Oct 6 '25 Sell $1.78 17,500 $31,150.00 1,518,893

Share on Social Networks: